Today: 20 May 2026
China probes Trip.com for monopoly conduct and the stock slides
14 January 2026
2 mins read

China probes Trip.com for monopoly conduct and the stock slides

BEIJING, Jan 15, 2026, 00:26 (GMT+8)

  • China’s antitrust authority has launched an investigation into Trip.com over alleged market power abuse
  • Trip.com confirmed it will cooperate and maintain normal operations
  • Shares of Trip.com fell in Hong Kong following the disclosure

China’s market watchdog launched an antitrust probe into Trip.com Group, the country’s largest online travel agency, amid allegations of monopolistic practices. Shares of the Hong Kong-listed company dropped 6.5%, closing at HK$569.50.

This move is significant as it pulls a major consumer-facing platform back under China’s strict anti-monopoly scrutiny, just as officials ramp up rhetoric on “unfair competition” in the internet sector. For investors, it revives a familiar anxiety: once a formal investigation kicks off, regulators can swiftly shift from issuing warnings to handing down fines.

The State Administration for Market Regulation (SAMR) said Trip.com is suspected of abusing its dominant market position—using its power to skew terms in its favor—but didn’t detail the specific allegations. Under China’s Anti-Monopoly Law, companies caught violating the rules can face fines ranging from 1% to 10% of their previous year’s revenue.

Trip.com announced it has been notified of an investigation by SAMR and promised to “actively cooperate” with the authorities. The company stressed that “its business operations remain normal” but offered no additional information. https://www.prnewswire.com/news-releases/a…

Bloomberg says the investigation is unfolding just weeks ahead of China’s Spring Festival holidays, a key travel season.

Regulatory probes into online platforms are now routine, said Li Chengdong, founder and chief analyst at Beijing-based e-commerce consultancy Dolphin, in an interview with the South China Morning Post. He described it as a sign that “antitrust enforcement could become normalised.” The report also highlighted that last week the State Council announced a market competition inquiry targeting food delivery platforms, though it didn’t specify which ones. https://www.scmp.com/tech/policy/article/3…

In December, a homestay industry association in Yunnan province reported complaints from its members targeting online travel agencies. The group is gathering evidence for potential action, accusing platforms of coercive contract terms, sudden commission increases — the fees taken from each booking — and restricting online traffic.

Trip.com is benefiting from a surge in travel demand. Its latest financial report showed third-quarter net revenue climbed 16% year over year, with accommodation reservation revenue up 18% compared to the same quarter in 2024.

The Trip.com case unfolds amid a policy environment still shaped by the last major crackdown on platforms. Back in 2021, China’s regulators slapped Alibaba with a record 18 billion yuan ($2.58 billion) fine following an antitrust probe that found the company had abused its dominant position. More recently, officials have voiced concerns over what they describe as excessive price competition, warning it damages businesses and fuels deflationary pressures.

Trip.com operates a wide-ranging online travel platform, selling hotel bookings, transport tickets, and travel packages. The company also provides services tailored to corporate travel.

But SAMR’s notice offered no specifics on what conduct was under scrutiny, no timeline, and no hint at the investigation’s scope. The worst-case scenario: a formal ruling and a fine connected to last year’s sales. Even if that doesn’t happen, a drawn-out probe could stall partnerships as hotels and smaller operators prepare for stricter checks on commissions and contract terms.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Broadcom stock slides after report China told firms to drop VMware, other foreign cyber tools
Previous Story

Broadcom stock slides after report China told firms to drop VMware, other foreign cyber tools

Citigroup stock drops after earnings: Russia hit, cost cuts in focus
Next Story

Citigroup stock drops after earnings: Russia hit, cost cuts in focus

Go toTop